ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Sarepta Therapeutics, Inc. clinical trials

Also known as AVI BioPharma.

The registry lists 52 studies whose lead sponsor is Sarepta Therapeutics, Inc.. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Keep track of what changes. Save the Sarepta Therapeutics, Inc. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
23
Terminated
14
Enrolling by invitation
5
Active, not recruiting
5
Recruiting
3
Withdrawn
2

Phase

Phase 1
30
Phase 2
19
Phase 3
9
Phase 4
1

Where

United States
39
United Kingdom
15
Italy
14
Spain
12
Germany
12
Belgium
11

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sarepta Therapeutics, Inc..

  • Sarepta Therapeutics, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    52 studies

Focus areas

Conditions Sarepta Therapeutics, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Muscular Dystrophy, Duchenne27Muscular Dystrophies19

Studies

Recruiting first, then most recently updated. Showing 50 of 52. Browse all 52 →